ES551656A0 - Un procedimiento para preparar un polipeptido que se puede utilizar en una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum - Google Patents

Un procedimiento para preparar un polipeptido que se puede utilizar en una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum

Info

Publication number
ES551656A0
ES551656A0 ES551656A ES551656A ES551656A0 ES 551656 A0 ES551656 A0 ES 551656A0 ES 551656 A ES551656 A ES 551656A ES 551656 A ES551656 A ES 551656A ES 551656 A0 ES551656 A0 ES 551656A0
Authority
ES
Spain
Prior art keywords
vaccine
polypeptide
preparing
procedure
plasmodium falciparum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551656A
Other languages
English (en)
Other versions
ES8704975A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of ES8704975A1 publication Critical patent/ES8704975A1/es
Publication of ES551656A0 publication Critical patent/ES551656A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES551656A 1985-02-07 1986-02-05 Un procedimiento para preparar un polipeptido que se puede utilizar en una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum Expired ES8704975A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69911585A 1985-02-07 1985-02-07

Publications (2)

Publication Number Publication Date
ES8704975A1 ES8704975A1 (es) 1987-04-16
ES551656A0 true ES551656A0 (es) 1987-04-16

Family

ID=24808000

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551656A Expired ES8704975A1 (es) 1985-02-07 1986-02-05 Un procedimiento para preparar un polipeptido que se puede utilizar en una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum

Country Status (19)

Country Link
EP (1) EP0191748B1 (es)
JP (2) JPH0698005B2 (es)
CN (1) CN86100979A (es)
AP (1) AP17A (es)
AT (1) ATE82322T1 (es)
AU (1) AU603054B2 (es)
DE (1) DE3687071T2 (es)
DK (1) DK62486A (es)
EG (1) EG17878A (es)
ES (1) ES8704975A1 (es)
GR (1) GR860351B (es)
HU (1) HU201803B (es)
IL (1) IL77788A0 (es)
MY (1) MY102249A (es)
NZ (1) NZ215034A (es)
OA (1) OA08199A (es)
PT (1) PT81967B (es)
YU (1) YU18186A (es)
ZA (1) ZA86797B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192626B1 (en) * 1985-02-07 1992-07-29 Smithkline Beecham Corporation Malaria vaccine
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
EP0252588A3 (en) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine
EP0254862A1 (en) * 1986-06-26 1988-02-03 BEHRINGWERKE Aktiengesellschaft Vaccines against protozoan parasites
JPH01501755A (ja) * 1986-11-04 1989-06-22 シントロ　コーポレイション 合成ｄｎａの構成および大ポリペプチドの合成におけるその使用
IT1198225B (it) * 1986-12-04 1988-12-21 Eniricerche Spa Polipeptidi immunologicamente attivi utili per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antisporozoita
EP0278940A3 (en) * 1987-01-30 1988-12-07 Smithkline Biologicals S.A. Hepatitis b virus surface antigens and hybrid antigens containing them
JPH0222300A (ja) * 1987-02-02 1990-01-25 Swiss Serum & Vaccine Inst Bern 免疫原性接合体およびその製法ならびに免疫を生ぜしめる方法
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
EP0321606B1 (de) * 1987-12-23 1993-09-29 IMMUNO Aktiengesellschaft Zelluläre amphipatische Proteine in aggregierten Formen und Verfahren zur Herstellung und Reinigung diese Proteine
CA2015722A1 (en) * 1989-05-03 1990-11-03 Mitchell S. Gross Malaria vaccine
CA2031468A1 (en) * 1989-12-08 1991-06-09 Mitchell S. Gross Malaria vaccine
KR101616572B1 (ko) 2009-05-05 2016-05-11 카딜라 핼쓰캐어 리미티드 홍역-말라리아 조합 백신
US20180153945A1 (en) * 2016-12-05 2018-06-07 The United States Of America, As Represented By The Secretary Of Agriculture Oral e. coli vector-based vaccine for prevention of coccidiosis in poultry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
DE3584300D1 (de) * 1984-02-21 1991-11-14 Nat Res Dev Herstellung von malaria-impfstoffen.
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor

Also Published As

Publication number Publication date
EP0191748A1 (en) 1986-08-20
HUT40917A (en) 1987-03-30
EG17878A (en) 1991-06-30
GR860351B (en) 1986-06-05
JPH07170995A (ja) 1995-07-11
PT81967A (en) 1986-03-01
AU5293686A (en) 1986-08-14
IL77788A0 (en) 1986-07-31
HU201803B (en) 1990-12-28
AU603054B2 (en) 1990-11-08
AP8600020A0 (en) 1986-02-01
ES8704975A1 (es) 1987-04-16
ATE82322T1 (de) 1992-11-15
JPS61181387A (ja) 1986-08-14
NZ215034A (en) 1989-07-27
OA08199A (en) 1987-10-30
JPH07102150B2 (ja) 1995-11-08
CN86100979A (zh) 1986-12-17
AP17A (en) 1988-04-02
DK62486D0 (da) 1986-02-07
MY102249A (en) 1992-05-15
DE3687071T2 (de) 1993-03-25
ZA86797B (en) 1986-09-24
DE3687071D1 (de) 1992-12-17
PT81967B (pt) 1988-07-01
DK62486A (da) 1986-08-08
JPH0698005B2 (ja) 1994-12-07
YU18186A (en) 1988-06-30
EP0191748B1 (en) 1992-11-11

Similar Documents

Publication Publication Date Title
ES553953A0 (es) Un metodo para preparar una particula que puede ser empleada como vacuna contra la infeccion por hepatitis b
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
DE3670209D1 (de) Schutzeinrichtung fuer eine in einen patienten einpflanzbare vorrichtung.
ES551657A0 (es) Un procedimiento para preparar una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum
AR242494A1 (es) Dispositivo para fijar una protesis dental
KR880701560A (ko) 개선된 백신 및 제조방법
ES545607A0 (es) Procedimiento para preparar una vacuna contra la coccidiosis
ATA260886A (de) Handstueck, insbesondere fuer zahnaerztliche zwecke
ES545606A0 (es) Procedimiento para preparar una vacuna contra la coccidiosis
IT1142667B (it) Composti a base di idrossidi di sol fossi-pirimidinio-piridinio e triazinio come agenti anti-ipertensivi e procedimento di preparazione
ES549200A0 (es) Procedimiento para preparar una solucion antigenica libre decelulas
NZ223174A (en) Peptides and multimers immunologically related to circumsporozoite protein; vaccines against plasmodium falciparum-induced malaria
IL78292A0 (en) Immunogenic antigen-carrier protein conjugate for use in a vaccine against malaria
DK62486D0 (da) Vaccine
PT100989A (pt) Vacina contra dermatomicoses e processo para a sua preparacao
DK238085A (da) Plantebeskyttelsesmiddel (antidotum), deri indgaaende benzoxazolyl- og benzthiazolylaminosyrer, disses fremstilling og deres anvendelse
IT1216898B (it) Procedimento e dispositivo per produrre una giuntatura.
DE69229899D1 (de) Schützendes malaria sporozoiten-oberflächenprotein immunogen und gen
ES541368A0 (es) Procedimiento y medios para frenar una escalera mecanica
ZA874589B (en) Vaccines against protozoan parasites
MX7582E (es) Procedimiento para la preparacion de una vacuna contra la babesiosis de bovino
IT8348851A0 (it) Procedimento per preparare una sostanza avente attivita' carcinostatica ed immunostimolante
DK567786A (da) Ikke-adjuvansholdig vaccine
FI886001L (fi) Menetelmä Plasmodium falciparum -proteiinien valmistamiseksi geeniteknisesti ja siinä käyttökelpoisia tuotteita
ES550006A0 (es) Procedimiento de obtencion de una vacuna para prevenir la hepatitis b.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401